(Q28222450)

2

0 references

Larissa Takser

3

0 references

Evelyne Rey

4

0 references

Michèle David

Journal of Obstetrics and Gynaecology Canada

5

0 references

language of work or name

English

0 references

publication date

October 2007

0 references

published in

0 references

volume

29

0 references

issue

10

0 references

page(s)

787-93

0 references

cites work

Placental pathologic features of preterm preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Thrombophilic disorders and fetal loss: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Heparin cofactor activity measured with an amidolytic method

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Unexpected relationship between plasma homocysteine and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Absence of association of thrombophilia polymorphisms with intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Analysis of repeated categorical data using generalized estimating equations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

How many repeated measures in repeated measures designs? Statistical issues for comparative trials

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Does heparin therapy improve pregnancy outcome in patients with thrombophilias?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Low-molecular-weight heparin for thrombophilia in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Preventing adverse obstetric outcomes in women with genetic thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932641-X

7 January 2021

10.1016/S1701-2163(16)32641-X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_iacwehgc4nax5mitt7pcrt7bdm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iacwehgc4nax5mitt7pcrt7bdm

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17915061

1 reference

Consolidated OpenCitations Corpus – April 2017